Should You Buy, Sell, or Hold TER Stock After a 312% Rise in One Year?
π TER shares have risen 312.4% in the last year, outperforming the Zacks Computer & Technology sector's 43.5% gain.
π€ AI-related demand now accounts for nearly 70% of Teradyne's Q1 2026 revenues, up from 60% previously.
π° The SemiTest segment broke the $1 billion revenue threshold with compute products making up 75% of SoC revenue.
π Robotics division delivered a fourth consecutive quarter of sequential growth, with Q1 2026 revenues up 32% YoY to $91 million.
π¬ New platforms like Photon 100 and Omnyx address critical needs in AI data center build-outs.
π€ Strategic partnerships include a JV for MultiLane Test Products and an expansion of collaboration with Flex in April 2026.
π Q2 2026 revenue guidance is set between $1.15 billion and $1.25 billion, implying an 86.43% YoY increase.
π΅ Non-GAAP earnings are projected at $1.86-$2.15 per share, suggesting a 249.12% YoY growth rate.
π The stock trades at a premium with a forward P/S of 11.38X and carries a Value Score of F.
π Zacks Investment Research assigns a Rank #1 (Strong Buy) rating, recommending accumulation.
- Teradyne is benefiting from a massive surge in AI infrastructure demand, with AI-related revenue reaching nearly 70% of total Q1 2026 sales.
- The company successfully broke the $1 billion revenue threshold for its SemiTest segment, driven by strong compute and memory test demand.
- Robotics division achieved four consecutive quarters of sequential growth, defying typical seasonal weakness with a 32% year-over-year increase in Q1 2026.
- Strategic acquisitions like TestInsight and the MultiLane Test Products JV are enhancing capabilities in high-speed I/O and data center interconnect testing.
- New product launches such as the Photon 100 platform target a TAM expansion opportunity of $300 million to $700 million annually.
- Partnership with Flex to deploy cobots and autonomous mobile robots expands Teradyne's footprint in manufacturing and data center environments.
- Q2 2026 revenue guidance of $1.15-$1.25 billion represents an 86.43% year-over-year increase, significantly beating the consensus estimate.
- Non-GAAP earnings projections of $1.86-$2.15 per share indicate a transformative 249.12% year-over-year growth rate.
- Teradyne stock is trading at a premium valuation with a forward 12-month Price/Sales ratio of 11.38X compared to the industry average of 10.29X.
- The company currently holds a Value Score of F, indicating it may be overvalued relative to its fundamentals.